News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Brennan David R
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| Brennan David R (Director) has filed a Form 4 on INSMED Inc|
Txns:
| Bought 10,000 shares
@ $30.15, valued at
$301.5k
|
|
| 07/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2020 |
4
| Brennan David R (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Granted 3,468 shares
@ $0
Granted 2,428 shares
@ $0 |
|
| 05/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2019 |
4
| Brennan David R (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Granted 2,726 shares
@ $0
Granted 1,908 shares
@ $0 |
|
| 05/16/2019 |
4
| Brennan David R (Director) has filed a Form 4 on INSMED Inc|
Txns:
| Granted 6,899 shares
@ $0 |
|
| 05/17/2018 |
4
| Brennan David R (Director) has filed a Form 4 on INSMED Inc|
Txns:
| Granted 6,066 shares
@ $0 |
|
| 05/11/2018 |
4
| Brennan David R (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Granted 2,174 shares
@ $0 |
|
| 07/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2017 |
4
| Brennan David R (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Granted 2,030 shares
@ $0 |
|
| 01/03/2017 |
3
| Brennan David R (Director) has filed a Form 3 on Innocoll Holdings plc |
| 05/23/2016 |
4
| Brennan David R (Director) has filed a Form 4 on INSMED Inc|
Txns:
| Granted 12,742 shares
@ $0 |
|
| 05/19/2016 |
4
| Brennan David R (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Granted 835 shares
@ $0
Granted 2,294 options to buy
@ $138.86, valued at
$318.5k
|
|
|
|